View Older Stories

Apr 21, 2026 04:00PM Quest Diagnostics (DGX) PT Raised to $230 at Barclays

Apr 21, 2026 02:47PM Quest Diagnostics (DGX) PT Raised to $225 at Evercore ISI

Apr 21, 2026 11:51AM Quest Diagnostics (DGX) PT Raised to $240 at Leerink Partners

Apr 21, 2026 06:49AM Quest Diagnostics (DGX) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY26 Guidance

Apr 8, 2026 09:45AM Quest Diagnostics (DGX) PT Lowered to $210 at Evercore ISI, added to TAP list

Apr 8, 2026 09:43AM Evercore Adjusts TAP Lists

Mar 2, 2026 09:02AM Quest Diagnostics launches AI tool to explain lab results

Feb 26, 2026 08:25AM Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief

Feb 10, 2026 12:35PM Quest Diagnostics (DGX) PT Raised to $215 at Citi

Feb 10, 2026 06:49AM Quest Diagnostics (DGX) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 Guidance

Feb 2, 2026 08:53AM Quest Diagnostics launches blood test for myeloma residual disease detection

Feb 2, 2026 02:43AM Barclays Upgrades Quest Diagnostics (DGX) to Overweight

Jan 30, 2026 06:13AM Barclays Upgrades Quest Diagnostics (DGX) to Overweight

Dec 1, 2025 08:32AM Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the U.S.

Nov 11, 2025 04:23PM Quest Diagnostics (DGX) Declares $0.8 Quarterly Dividend; 1.7% Yield

Oct 22, 2025 08:54AM Quest Diagnostics (DGX) PT Raised at Truist; '3Q Ahead As Core Trends Remain Strong'

Oct 21, 2025 01:09PM Quest Diagnostics (DGX) PT Raised to $210 at Leerink Partners

Oct 21, 2025 06:46AM Quest Diagnostics (DGX) Tops Q3 EPS by 10c; updates guidance

Sep 4, 2025 09:32AM Quest Diagnostics launches pharmacogenomics testing service

Aug 25, 2025 08:52AM Quest Diagnostics wins FDA breakthrough status for cancer test

Aug 25, 2025 02:59AM Baird Downgrades Quest Diagnostics (DGX) to Neutral

Aug 7, 2025 09:09AM Mass General Brigham launches clinical trials for Haystack MRD cancer test

Jul 22, 2025 06:48AM Quest Diagnostics (DGX) Tops Q2 EPS by 5c; offers guidance

Jul 15, 2025 07:57AM Quest Diagnostics launches Oropouche virus testing

Jul 9, 2025 08:24AM Quest Diagnostics to add FDA-cleared Alzheimer's blood test this summer

May 6, 2025 05:04AM Quest Diagnostics (DGX) PT Raised to $190 at JPMorgan

Apr 22, 2025 06:44AM Quest Diagnostics (DGX) Tops Q1 EPS by 5c; offers guidance

Apr 2, 2025 07:07AM Quest Diagnostics (DGX) Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Apr 2, 2025 04:03AM Redburn-Atlantic Starts Quest Diagnostics (DGX) at Buy

Mar 26, 2025 09:40AM Truist on Quest Diagnostics (DGX): 'We Continue to See Solid Organic Growth'

Mar 19, 2025 07:55AM Quest Diagnostics (DGX) to Highlight Strategic Priorities to Drive Sustainable Growth

Mar 4, 2025 05:05AM Citi Downgrades Quest Diagnostics (DGX) to Neutral

Feb 24, 2025 02:35PM Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Feb 4, 2025 05:17AM Quest Diagnostics (DGX) PT Raised to $180 at JPMorgan

Jan 31, 2025 12:21PM Quest Diagnostics (DGX) PT Raised to $178 at Mizuho

Jan 30, 2025 02:00PM Quest Diagnostics (DGX) PT Raised to $190 at Jefferies

Jan 30, 2025 06:48AM Quest Diagnostics (DGX) Raises Quarterly Dividend 6.7% to $0.80; 2.1% Yield

Jan 30, 2025 06:46AM Quest Diagnostics (DGX) Tops Q4 EPS by 4c; offers guidance

Jan 8, 2025 08:42AM Quest Diagnostics (DGX) Appoints Adrienne Brott as Chief Quality and Regulatory Affairs Officer

Jan 6, 2025 06:19AM Leerink Partners Upgrades Quest Diagnostics (DGX) to Outperform

Dec 19, 2024 08:03AM Mainz Biomed (MYNZ) Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

Dec 17, 2024 04:27AM Morgan Stanley Upgrades Quest Diagnostics (DGX) to Overweight

Dec 9, 2024 04:06PM Jefferies Starts Quest Diagnostics (DGX) at Buy

Nov 25, 2024 07:38AM Quest Diagnostics (DGX) PT Lowered to $181 at Baird

Oct 23, 2024 07:53AM Quest Diagnostics (DGX) Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development

Oct 23, 2024 06:05AM Quest Diagnostics (DGX) PT Raised to $165 at Leerink Partners

Oct 23, 2024 03:25AM Baird Upgrades Quest Diagnostics (DGX) to Outperform

Oct 22, 2024 12:20PM CFRA Upgrades Quest Diagnostics (DGX) to Buy

Oct 22, 2024 06:46AM Quest Diagnostics (DGX) Tops Q3 EPS by 4c; raises guidance

Oct 14, 2024 08:50AM Quest Diagnostics (DGX) Completes Acquisition of Lab Assets from OhioHealth

View Older Stories